Nanovis specializes in advanced biomaterials and coatings designed to enhance the performance of medical devices. Their proprietary technologies focus on improving biocompatibility and reducing the risk of infection, which are critical factors in the success of implants and surgical instruments. By utilizing nanotechnology, Nanovis develops surface modifications that promote better integration with human tissue, thereby improving patient outcomes and device longevity.

The company’s product pipeline includes a range of innovative solutions aimed at addressing specific challenges in the medical field, such as antimicrobial properties and enhanced mechanical strength. Their research emphasizes the importance of surface interactions at the nanoscale, allowing for tailored responses to biological environments. This approach not only enhances the functionality of existing medical devices but also paves the way for the development of next-generation implants that can better meet the needs of patients and healthcare providers.

United States

NANOVIS is a rapidly growing nanotechnology surface company. Our scientists use a broad portfolio of advanced nanotechnologies designed to improve spine, orthopedic, and dental surgical outcomes.  nanoVIS Ti ™ Surface Technology received FDA nanotechnology designation and is cleared on commercially pure titanium and titanium alloy implants.

Nanovis

Company Details